Bilsborough J, Baumgart K, Bathurst I, Barr P, Good M F
Queensland Institute of Medical Research, Royal Brisbane Hospital, Brisbane, Australia.
Acta Trop. 1997 May 15;65(2):59-80. doi: 10.1016/s0001-706x(97)00648-7.
Recent work has suggested that important B- and T-cell epitopes on the circumsporozoite protein (CSP) of Plasmodium vivax lie external to the major repeat regions of the protein. We have studied two naturally exposed human populations (Caucasian and Papua New Guineans) and determined the antibody response to yeast-derived recombinant CSPs, overlapping synthetic peptides spanning amino acids 76 348 of the Belem P. vivax CSP and overlapping peptides representing the variant repeats of the VK247 strain of P. vivax. We have demonstrated that the P. vivax CSP-specific antibody response is directed towards areas within the repeat region as well as areas external to this; but the dominant epitopes recognized by the two populations studied, were distinct. One epitope, lying external to the repeats and recognized by both populations, partially overlaps an area of the protein referred to as region II-plus. Sera from malaria-exposed Papua New Guineans and Thais contained antibodies to this epitope (V22, single letter amino acid sequence TCGVGVRVRRRVNAANKKPE) which were capable of recognizing sporozoites, as determined by quantitative inhibition IFA. Seventeen percent of PNG sera had antibodies to this peptide compared with 33% who had antibodies to the central repeats of the protein. Immunization of mice with recombinant CSP did not induce antibodies to V22. However, immunization with overlapping peptide epitopes representing this region (V21 or V22) induced specific antibodies but only two sera recognized both V21 and V22 and, by inference, the overlapping peptide sequence (TCGVGVRVRR). Antibodies in these two sera could bind recombinant CSP in ELISA; however, in contrast, nine sera which recognized either V21 or V22 alone did not bind CSP. Only one of two sera containing antibodies recognizing CSP stained P. vivax sporozoites. This serum also recognized an epitope dependent upon two amino acids aminoterminal to V22. These data suggest that the fine specificity of antibodies is a critical determinant for binding to both recCSP and sporozoites.
近期研究表明,间日疟原虫环子孢子蛋白(CSP)上重要的B细胞和T细胞表位位于该蛋白主要重复区域之外。我们研究了两个自然暴露的人群(高加索人和巴布亚新几内亚人),并确定了他们对酵母衍生的重组CSP、覆盖贝伦间日疟原虫CSP氨基酸76至348的重叠合成肽以及代表间日疟原虫VK247株变异重复序列的重叠肽的抗体反应。我们已经证明,间日疟原虫CSP特异性抗体反应针对重复区域内以及该区域之外的区域;但所研究的两个人群识别的主要表位是不同的。一个位于重复序列之外且被两个人群识别的表位,部分重叠于该蛋白被称为II +区域的一个区域。来自暴露于疟疾的巴布亚新几内亚人和泰国人的血清含有针对该表位(V22,单字母氨基酸序列TCGVGVRVRRRVNAANKKPE)的抗体,通过定量抑制免疫荧光法测定,这些抗体能够识别子孢子。17%的巴布亚新几内亚人血清含有针对该肽的抗体,而33%的人血清含有针对该蛋白中央重复序列的抗体。用重组CSP免疫小鼠未诱导出针对V22的抗体。然而,用代表该区域的重叠肽表位(V21或V22)免疫诱导出了特异性抗体,但只有两份血清同时识别V21和V22,据此推断,也识别重叠肽序列(TCGVGVRVRR)。这两份血清中的抗体在酶联免疫吸附测定中能够结合重组CSP;然而,相比之下,仅识别V21或V22的九份血清不能结合CSP。含有识别CSP抗体的两份血清中只有一份能够对间日疟原虫子孢子进行染色。该血清还识别一个依赖于V22氨基末端两个氨基酸的表位。这些数据表明,抗体的精细特异性是与重组CSP和子孢子结合的关键决定因素。